4:31 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Lucid Diagnostics Nasdaq/NYSE Compliance Notice
Lucid Diagnostics Inc. received a deficiency notice from Nasdaq on October 12, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has 180 calendar days, until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days.
- Counterparty
- Nasdaq
- Term
- 180 days